Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance.
- NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance.
- NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_assertion evidence source_evidence_literature NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance.
- NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_assertion SIO_000772 15256482 NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance.
- NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_assertion wasDerivedFrom befree-20140225 NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance.
- NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_assertion wasGeneratedBy ECO_0000203 NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance.